Rosa E. Menjivar

1.4k total citations · 2 hit papers
12 papers, 461 citations indexed

About

Rosa E. Menjivar is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Rosa E. Menjivar has authored 12 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Rosa E. Menjivar's work include Pancreatic and Hepatic Oncology Research (6 papers), Immune cells in cancer (5 papers) and Phagocytosis and Immune Regulation (4 papers). Rosa E. Menjivar is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Immune cells in cancer (5 papers) and Phagocytosis and Immune Regulation (4 papers). Rosa E. Menjivar collaborates with scholars based in United States, United Kingdom and Switzerland. Rosa E. Menjivar's co-authors include Marina Pasca di Magliano, Eileen S. Carpenter, Katelyn L. Donahue, Kristee Brown, Ashley Velez-Delgado, Zeribe C. Nwosu, Costas A. Lyssiotis, Howard C. Crawford, Yaqing Zhang and Fatima Lima and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Cancer Research.

In The Last Decade

Rosa E. Menjivar

12 papers receiving 454 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment

2024 119 citations Kevin M. Tharp, Kelly Kersten et al. Nature Cancer profile →
Arginase 1 is a key driver of immune suppression in pancreatic cancer

2023 96 citations Rosa E. Menjivar, Zeribe C. Nwosu et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa E. Menjivar United States	8	207	203	167	116	37	12	461
Jane Antony United States	10	207 1.0×	165 0.8×	185 1.1×	79 0.7×	46 1.2×	16	448
Raziye Piranlioglu United States	9	199 1.0×	276 1.4×	251 1.5×	92 0.8×	39 1.1×	13	517
Linda Ziani France	6	206 1.0×	326 1.6×	370 2.2×	152 1.3×	46 1.2×	7	603
Katelyn L. Donahue United States	7	147 0.7×	145 0.7×	157 0.9×	97 0.8×	29 0.8×	14	335
Liwei Xiao China	5	244 1.2×	128 0.6×	88 0.5×	198 1.7×	35 0.9×	7	434
Kevin Alicea-Torres United States	4	141 0.7×	278 1.4×	204 1.2×	95 0.8×	48 1.3×	5	434
Brian E. Hsu Canada	7	146 0.7×	236 1.2×	162 1.0×	60 0.5×	31 0.8×	9	425
Tung Bui Canada	10	273 1.3×	115 0.6×	195 1.2×	87 0.8×	32 0.9×	12	470
Totakura V. S. Kumar India	6	235 1.1×	108 0.5×	215 1.3×	118 1.0×	26 0.7×	7	407
Shimrit Mayer Israel	8	176 0.9×	120 0.6×	187 1.1×	70 0.6×	36 1.0×	8	362

Countries citing papers authored by Rosa E. Menjivar

Since Specialization

Citations

This map shows the geographic impact of Rosa E. Menjivar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa E. Menjivar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa E. Menjivar more than expected).

Fields of papers citing papers by Rosa E. Menjivar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa E. Menjivar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa E. Menjivar. The network helps show where Rosa E. Menjivar may publish in the future.

Co-authorship network of co-authors of Rosa E. Menjivar

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa E. Menjivar. A scholar is included among the top collaborators of Rosa E. Menjivar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa E. Menjivar. Rosa E. Menjivar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Nwosu, Zeribe C., Rosa E. Menjivar, Dae-Ho Kim, et al.. (2025). Multidimensional analyses identify genes of high priority for pancreatic cancer research. JCI Insight. 10(4). 3 indexed citations

Tharp, Kevin M., Kelly Kersten, Ori Maller, et al.. (2024). Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nature Cancer. 5(7). 1045–1062. 119 indexed citations breakdown →

Menjivar, Rosa E., Zeribe C. Nwosu, Wenting Du, et al.. (2023). Arginase 1 is a key driver of immune suppression in pancreatic cancer. eLife. 12. 96 indexed citations breakdown →

Menjivar, Rosa E., Nina G. Steele, Samantha B. Kemp, et al.. (2023). Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer. Cancer Immunology Research. 12(1). 91–106. 21 indexed citations

AminiTabrizi, Roya, Hardik Shah, Rosa E. Menjivar, et al.. (2023). Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis. eLife. 12. 32 indexed citations

Scales, Michael K., Ashley Velez-Delgado, Nina G. Steele, et al.. (2022). Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. PLoS Genetics. 18(7). e1010315–e1010315. 18 indexed citations

Du, Wenting, Rosa E. Menjivar, Katelyn L. Donahue, et al.. (2022). WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer. The Journal of Experimental Medicine. 220(1). 35 indexed citations

Kemp, Samantha B., Eileen S. Carpenter, Nina G. Steele, et al.. (2021). Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1. Cancer Research. 81(16). 4305–4318. 112 indexed citations

Velez-Delgado, Ashley, Katelyn L. Donahue, Kristee Brown, et al.. (2021). Abstract PR-016: Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming. Cancer Research. 81(22_Supplement). PR–16. 1 indexed citations

10.

Menjivar, Rosa E., Ethan M. Jewett, Wolfgang Döhle, et al.. (2019). Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2). BMC Pharmacology and Toxicology. 20(1). 67–67. 2 indexed citations

11.

Menjivar, Rosa E., Christopher J. Halbrook, Fatima Lima, et al.. (2019). Abstract A31: Investigating the effect of myeloid Arg1 deletion on tumor growth and CD8+ T-cell infiltration and activation in pancreatic cancer. Cancer Research. 79(24_Supplement). A31–A31. 2 indexed citations

12.

Menjivar, Rosa E., et al.. (2011). A Genome-Wide Immunodetection Screen in S. cerevisiae Uncovers Novel Genes Involved in Lysosomal Vacuole Function and Morphology. PLoS ONE. 6(8). e23696–e23696. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact